A61P 1 - Drugs for disorders of the alimentary tract or the digestive system

Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
12/2002
12/05/2002	CA2448626A1 Carbamate and oxamide compounds as inhibitors of cytokine production
12/05/2002	CA2448362A1 B7 related protein-2 molecules and uses thereof
12/05/2002	CA2448348A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
12/05/2002	CA2448306A1 Method for treating fibrotic diseases or other indications
12/05/2002	CA2448294A1 Method for treating fibrotic diseases or other indications vi
12/05/2002	CA2448248A1 Pharmaceutical composition comprising a tricyclic compound for the prevention or treatment of skin diseases
12/05/2002	CA2448198A1 5-substituted-2-arylpyridines as crf1 modulators
12/05/2002	CA2448148A1 Carbohydrate-associated proteins
12/05/2002	CA2448101A1 Process for preparing a thialzole ppar-ligand and polymorphs thereof
12/05/2002	CA2448062A1 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals
12/05/2002	CA2447879A1 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof
12/05/2002	CA2447475A1 Hydantion derivatives as inhibitors of matrix metalloproteinases
12/05/2002	CA2446723A1 Antibodies that immunospecifically bind to trail receptors
12/05/2002	CA2443713A1 Proteins associated with cell growth, differentiation, and death
12/05/2002	CA2443346A1 Anticholinergic compounds and methods of use
12/04/2002	EP1262192A2 Compositions and methods for human gastrointestinal health
12/04/2002	EP1262181A1 Urease inhibitors
12/04/2002	EP1261712A2 Proteins named fctrx and nucleic acids encoding same
12/04/2002	EP1261694A2 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof
12/04/2002	EP1261643A1 Composition for inhibiting macrophage activity
12/04/2002	EP1261640A2 Inflammation-related gene
12/04/2002	EP1261639A2 Chondromodulin-i related peptide
12/04/2002	EP1261636A2 Human protein kinases and protein kinase-like enzymes
12/04/2002	EP1261635A1 Human polynucleotides, polypeptides, and antibodies
12/04/2002	EP1261613A1 Gastro-specific prodrugs
12/04/2002	EP1261611A2 Inhibitors of hepatitis c virus ns3 protease
12/04/2002	EP1261605A1 Benzoxazole derivatives as tnf and pde iv inhibitors
12/04/2002	EP1261604A1 Compounds having antitumor activity: process for their preparation and pharmaceutical compositions containing them
12/04/2002	EP1261601A1 Substituted indoles for modulating nfkb activity
12/04/2002	EP1261590A1 Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases
12/04/2002	EP1261586A2 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase iv, processes for their preparation, and their use
12/04/2002	EP1261585A1 Substituted indole mannich bases
12/04/2002	EP1261379A2 Genetic modification of the lung as a portal for gene delivery
12/04/2002	EP1261378A2 Biodegradable immunomodulatory formulations and methods for use thereof
12/04/2002	EP1261372A2 Method of treating cancer with anti-neurotrophin agents
12/04/2002	EP1261368A2 Lipase-containing composition and methods of use thereof
12/04/2002	EP1261361A1 Oral, nasal and pulmonary dosage formualtions of copolymer 1
12/04/2002	EP1261349A1 Compounds with chelation affinity and selectivity for first transition series elements and their use
12/04/2002	EP1261347A1 Therapeutic compositions and methods for treatingperiodontitis with antiinflamatory compounds
12/04/2002	EP1261339A1 Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections
12/04/2002	EP1261337A2 Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors
12/04/2002	EP1261336A2 Il-8 receptor antagonists
12/04/2002	EP1261331A1 Method and compositions for treating fibrotic diseases
12/04/2002	EP1261330A2 Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and in lower animals
12/04/2002	EP1261329A2 Il-8 receptor antagonists
12/04/2002	EP1261328A1 Il-8 receptor antagonists
12/04/2002	EP1261324A2 Tramadol for the treatment of functional gastrointestinal disorders
12/04/2002	EP1261323A2 Method of treating gastrointestinal tract disease with purinergic receptor agonists
12/04/2002	EP1261259A1 Treatment of infection in animals
12/04/2002	EP1180026B1 Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases
12/04/2002	EP1143805B1 Method for reducing incidence of ascites in poultry by aid of natamycin
12/04/2002	EP1097139B1 Quinoline derivatives
12/04/2002	EP1058683B1 Farnesyl transferase inhibitors having a piperidine structure and process for preparation thereof
12/04/2002	EP1030867A4 Mammalian milk growth factor
12/04/2002	EP1001930B1 N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
12/04/2002	EP0928291B1 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
12/04/2002	EP0820306B1 Pharmaceutical composition containing pectin and a phospholipid, used as an antidiarrheal and antiulcer agent
12/04/2002	EP0814756B1 Method for preparing a preparation for bleaching teeth or for treating skin complaints and mucous membrane disorders
12/04/2002	EP0752863B1 Use of biopolymers for digestive tract injuries treatment
12/04/2002	EP0742218B1 Pyrrolopyridazine derivative
12/04/2002	EP0719285B1 Il8 inhibitors
12/04/2002	CN1383386A Drug delivery device for insertion in vagina, rectum of nasal cavity
12/04/2002	CN1382679A Process for extracting free anthraquinone from rhuhbarb and its medical application
12/04/2002	CN1382487A 'Kuijiean' suppository
12/04/2002	CN1382476A Application of yellowstem milkwort in preparing medicines
12/04/2002	CN1382474A Chinese medicine for treating periodontal disease and its preparing process and application
12/04/2002	CN1382470A 2-in-1 Yakangwang for preventing and treating odontopathy
12/04/2002	CN1382468A Weihanning for treating cold in stomach
12/04/2002	CN1382460A Chinese-medicinal capsule for treating hepatitis B and its preparing process
12/04/2002	CN1382454A Medicine for treating gastrosis and its preparing process
12/04/2002	CN1382439A Application of sophocarpidine oxide in preparing medicine to treat ulcerative colitis
12/04/2002	CN1382435A Application of sodium ferulate in preparing medicine to prevent and cure heptofibrosis
12/04/2002	CN1095381C Medicine for treating gastropathy and its prepn. method
12/04/2002	CN1095379C Chinese medicine for detoxicating wound and its preparing process
12/04/2002	CN1095366C Application of N-aceto-aminoglucose in medicinal preparation for curing intestinal diseases
12/03/2002	US6489365 Ltb4-antagonistic compounds for treatment of inflammation, allergy or gastropathy induced by non-steroidal antiinflammatory agents in a warm-blooded animals
12/03/2002	US6489353 Antiinflammatory agents; autoimmune diseases; central nervous system disorders
12/03/2002	US6489349 Treating an autoimmune disorder with an alkylamine substituted pyridine
12/03/2002	US6489346 Substituted benzimidazole dosage forms and method of using same
12/03/2002	US6489332 A1 adenosine receptor antagonists
12/03/2002	US6489328 Heterocyclic compounds useful as inhibitors of tyrosine kinases
12/03/2002	US6489323 Inhibiting no production from l-arginine, as seen in disease states such as arthritis and systemic hypotension associated with septic and/or toxic shock
12/03/2002	US6489321 Nonpeptide substituted benzothiazepines as vasopressin antagonists
12/03/2002	US6489310 Enteral composition which comprises a protein source, a lipid source, a carbohydrate source, and a fibre blend comprising pea inner fibres, pea outer envelope fibres, inulin, and fructo-oligosaccharides
12/03/2002	US6489298 Contulakin-G, analogs thereof and uses thereof
12/03/2002	US6489295 Antagonists of intestinotrophic GLP-2 peptides
12/03/2002	US6489294 Truncated insulin-like growth factor binding protein-5 having mitogenic activity
12/03/2002	US6488969 Method for reducing blood ammonia concentration
12/03/2002	US6488967 Gastric acid secretion
12/03/2002	US6488960 Corticosteroid formulation
12/03/2002	US6488923 Inhibits elastase; inhibits inflammations; used for the preparation of a vasoregulatory and or collagen activating medicament and to treat gingivitis.
12/03/2002	CA2213198C Gene therapy by anti-tgf-b agents
12/03/2002	CA2126103C Transfection of lung via aerosolized transgene delivery
12/03/2002	CA2074933C Thiazole derivatives as active superoxide radical inhibitors
11/2002
11/28/2002	WO2002095391A1 Methods and formulations for increasing the affinity of a1 adenosine receptor ligands for the a1 adenosine receptor
11/28/2002	WO2002095067A2 INTERFERON α-14 POLYMORPHISM
11/28/2002	WO2002095020A1 A gene and uses therefor
11/28/2002	WO2002095012A1 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders
11/28/2002	WO2002095011A2 Inactivation of genes of the mep pathway
11/28/2002	WO2002094990A2 Receptors and membrane-associated proteins

1 ... 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 ... 1258